AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Insuglo M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Neiss Labs Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Insuglo M 1mg/500mg Tablet

DiaBeta-Duo 1mg/500mg tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta-Duo with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this treatment even if feeling well or experiencing controlled blood sugar; discontinuation without medical advice risks elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are crucial for diabetes control. The primary adverse reaction is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, lightheadedness, headache, tremors—and appropriate countermeasures. Maintain regular meals and carry a readily available glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to use, as it may be unsuitable. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Regular blood glucose monitoring is essential; your physician may also order blood tests to track blood cell counts and liver function.

Uses of Insuglo M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Insuglo M 1mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Insuglo M 1mg/500mg Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Insuglo M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Insuglo M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Insuglo M 1mg/500mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume this medication with a meal.

How Insuglo M 1mg/500mg Tablet works:

Insuglo M tablets (1mg glimepiride/500mg metformin) combine two diabetes medications. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Insuglo M 1mg/500mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Insuglo M 1mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation and Insuglo M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Insuglo M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Insuglo M 1mg/500mg tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low starting dose is typically recommended; however, the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Insuglo M 1mg/500mg Tablet :

Should you forget to take your Insuglo M 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Insuglo M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Insuglo M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Insuglo M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Insuglo M 1mg/500mg Tablets and seek immediate medical attention.
Insuglo M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Insuglo M 1mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Insuglo M 1mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Insuglo M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Insuglo M 1mg/500mg Tablet and alcohol is unsafe. Alcohol can exacerbate the drug's effects, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Insuglo M 1mg/500mg Table...
35
MRP 40
12% off